Ericsson A, Kumlien C, Ching S, Carlson E, Molassiotis A Impact on Quality of Life of Men with Screening-Detected Abdominal Aortic Aneurysms Attending Regular Follow ups: A Narrative Literature Review. Eur J Vasc Endovasc Surg. 2019 Apr;57(4):589-596. doi: 10.1016/j.ejvs.2018.10.012. Epub 2019 Mar 22.
Lyttkens L, Wanhainen A, Svensjo S, Hultgren R, Bjorck M, Jangland E Systematic Review and Meta-Analysis of Health Related Quality of Life and Reported Experiences in Patients With Abdominal Aortic Aneurysm Under Ultrasound Surveillance. Eur J Vasc Endovasc Surg. 2020 Mar;59(3):420-427. doi: 10.1016/j.ejvs.2019.07.021. Epub 2020 Jan 10.
Nana P, Dakis K, Brodis A, Spanos K, Kouvelos G Circulating Biomarkers for the Prediction of Abdominal Aortic Aneurysm Growth. J Clin Med. 2021 Apr 16;10(8):1718. doi: 10.3390/jcm10081718.
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999 Dec;11(6):319-26. doi: 10.1038/sj.ijir.3900472.
Scott RA, Bridgewater SG, Ashton HA Randomized clinical trial of screening for abdominal aortic aneurysm in women. Br J Surg. 2002 Mar;89(3):283-5. doi: 10.1046/j.0007-1323.2001.02014.x.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
